The lack of T-cell infiltration in KS lesions and the robust ADAM12 expression in both human KS lesions and the L1T2 mouse xenografts make ADAM12 an interesting potential target and biomarker. This evidence concerns the gene ADAM12 and Kaposi's sarcoma.